The study was undertaken by members of Coopers & Lybrand Health and Community Services Division in cooperation with the National Drug and Alcohol Research Centre (NDARC). The review was conducted under the auspices of a Steering Committee, who monitored the conduct of the study, and provided advice on its methodology and direction.
In undertaking this review, a structured approach was adopted, which comprised a number of processes:
- A review of existing research literature reviewing private methadone programs in Australia.
- An extensive consultative approach covering major stakeholders in all jurisdictions in Australia in both the public and private sectors, including:
- representatives of Commonwealth and State health authorities
- Associations and Colleges of relevant professions of medicine
- private and public medical practitioners, nursing and support personnel, pharmacists, pathologists and other health providers
- clients, current and former, of methadone maintenance programs and
- peak body user groups.
- Distribution of a questionnaire to all State health authorities seeking data on activities in methadone programs in both the public and private sectors, together with costs incurred in the public sector.
- A review of a 10% sample of Medicare data provided by the Commonwealth Department of Human Services and Health pertaining to services provided to clients who received services under Medicare Item Number 66343.
- Distribution of a questionnaire to private practitioners involved in methadone treatment in New South Wales and Victoria to identify treatment patterns in the private sector.
Top of page